Tag: Valiant Navion

Medtronic presents one-year Valiant Navion, four-year ANCHOR registry clinical outcomes

Medtronic has announced one-year outcomes for the Valiant Navion thoracic stent graft system for thoracic endovascular repair (TEVAR) and four-year clinical outcomes from the ANCHOR...

Medtronic announces Shonin approval and launch of the Valiant Navion thoracic...

Medtronic today announced Shonin approval from the Ministry of Health, Labour and Welfare (MHLW) and the launch of the Valiant Navion thoracic stent graft...

BIBA Briefings: Medtronic receives US FDA Breakthrough Device Designation for complex...

The US Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Medtronic for its novel Valiant thoracoabdominal aneurysm (TAAA) stent graft. A...

Medtronic receives FDA breakthrough device designation for its Valiant Navion LSA...

Medtronic today announced it has received breakthrough device designation from the US Food and Drug Administration (FDA) for its Valiant TAAA stent graft system...

Design of Valiant Navion “improves upon current-generation TEVAR”

In the Aortic Podium 1st session at the 2019 Charing Cross Symposium (CX; 15–18 April, London, UK), Fabio Verzini (Turin, Italy) reported the 30-day...

FDA approves Valiant NAVION for inclusion in physician-sponsored IDE

The Valiant NAVION stent graft system (Medtronic) has been approved by the US Food and Drug Administration (FDA) for inclusion in a physician-sponsored investigational...

Valiant Navion receives CE mark approval

CE mark approval has been granted for the Valiant Navion thoracic stent graft system (Medtronic) for the minimally invasive repair of all lesions of...

Valiant Navion thoracic stent graft receives FDA approval

The US Food and Drug Administration (FDA) has approved Valiant Navion thoracic stent graft system (Medtronic) for the minimally invasive repair of all lesions...